title: Unravelling the role of denosumab in prostate cancer.
authors.affiliation: Division of Hematology and Oncology, George Washington University Medical Center, Washington DC 20037, USA. jaragonching@mfa.gwu.edu
authors.forename: Jeanny B
authors.initials: JB
authors.lastname: Aragon-Ching
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D000069448:Denosumab; D004164:Diphosphonates / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology*; D053245:RANK Ligand / Q000627:therapeutic use*; D000077211:Zoledronic Acid
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D053245:RANK Ligand; D000069448:Denosumab; D000077211:Zoledronic Acid